GPC3 and hepatocellular carcinoma: Gao W et al. have reported that the antibodies specifically targeting the HS chains of GPC3 interfere with the interaction between Wnt3a and GPC3, which in turn blocks Wnt3a/β-catenin signaling [115] and thus can inhibit the proliferation of HCC cells in vitro and in vivo.